PEP-MASK
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Overview
PEP-MASK is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
PEP-MASK clinical trials
Explore related
Medical disclaimer. This page summarizes research about PEP-MASK for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.